Over-expression of VEGF in marrow stromal cells promotes angiogenesis in rats with cerebral infarction via the synergistic effects of VEGF and Ang-2.
10.1007/s11596-012-1025-3
- Author:
Tianbao LAI
1
;
Man LI
;
Lifang ZHENG
;
Yanling SONG
;
Xiaoli XU
;
Yuanjin GUO
;
Yuan ZHANG
;
Zongsheng ZHANG
;
Yuanwu MEI
Author Information
1. Department of Neurology, Huazhong University of Science and Technology, Wuhan, China. dr.laitianbao@qq.com
- Publication Type:Journal Article
- MeSH:
Angiopoietin-2;
genetics;
metabolism;
Animals;
Bone Marrow;
metabolism;
pathology;
Cerebral Infarction;
genetics;
metabolism;
pathology;
Male;
Neovascularization, Pathologic;
genetics;
pathology;
Rats;
Rats, Sprague-Dawley;
Stromal Cells;
metabolism;
pathology;
Vascular Endothelial Growth Factor A;
genetics;
metabolism
- From:
Journal of Huazhong University of Science and Technology (Medical Sciences)
2012;32(5):724-731
- CountryChina
- Language:English
-
Abstract:
bThis study explored whether the transplantation of modified marrow stromal cells (MSCs) has angiogenic effects in a left middle cerebral artery occlusion infarction/reperfusion (MCAO I/R) rat model and preliminarily examined the mechanism of angiogenesis following cerebral infarction. MSCs were isolated by using a direct adherent method and cultured. Vascular endothelial growth factor (VEGF) was transfected into MSCs by employing the liposome transfection. The transfection efficiency was measured by the optical density method. The protein expression of VEGF gene before and after transfection was measured by Western blotting. SD rat model of transient occlusion of the left middle cerebral artery was established by using an approach of intra-luminal occlusion. Tetrazolium (TTC) and HE staining were performed to observe the cerebral infarction. ELISAs were used to measure the levels of VEGF in the rat cerebral tissues. The expression patterns of angiopoietin-2 (Ang-2) and CD34 in cells surrounding the area of infarction were immunohistochemistrically observed. Ang-2 protein expression in the tissue surrounding the area of infarction was measured by Western blotting. VEGF expression in the MSCs increased after transfection at a rate of approximately 28%±3.4%. ELISA showed that the expression of VEGF in the cerebral tissue was significantly increased after induction of infarction, peaking on the 4th day and decreasing to the levels of the sham surgery group (normal) within 7 to 10 days. The VEGF level was significantly higher at each time point in the VEGF-MSC and MSC groups compared to the model group. Moreover, the VEGF level was higher in the VEGF-MSC group than in the MSC group and stayed relatively high until the 10th day. The immunohistochemical results showed that 10 days after the infarction, the number of Ang-2 and CD34-expressing cells in the area surrounding the infarction was significantly higher in the VEGF-MSC group and the MSC group compared to the model group. Moreover, the VEGF level was higher in the VEGF-MSC group than the MSC group. A similar trend in Ang-2 protein expression was revealed by Western blotting. In the MCAO rat model transfected with modified MSCs over-expressing VEGF, compared to the MSC transplantation group, the concentration of VEGF was significantly increased in the brain tissue after cerebral infarction. In addition, the level of Ang-2 was up-regulated, with angiogenesis promoted, the blood supply to the areas surrounding the cerebral infarction increased, and neurological function improved. We are led to speculate that the synergistic effects of VEGF and Ang-2 may be responsible for the angiogenesis following cerebral infarction.
